- Home
- ONB vs HALO Comparison
ONB vs HALO Comparison
Compare ONB & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONB
- HALO
- Stock Information
- Founded
- ONB 1834
- HALO 1998
- Country
- ONB United States
- HALO United States
- Employees
- ONB N/A
- HALO N/A
- Industry
- ONB Major Banks
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONB Finance
- HALO Health Care
- Exchange
- ONB Nasdaq
- HALO Nasdaq
- Market Cap
- ONB 7.3B
- HALO 7.3B
- IPO Year
- ONB N/A
- HALO N/A
- Fundamental
- Price
- ONB $23.46
- HALO $57.75
- Analyst Decision
- ONB Buy
- HALO Buy
- Analyst Count
- ONB 7
- HALO 9
- Target Price
- ONB $27.00
- HALO $62.78
- AVG Volume (30 Days)
- ONB 2.8M
- HALO 1.1M
- Earning Date
- ONB 01-21-2025
- HALO 02-18-2025
- Dividend Yield
- ONB 2.39%
- HALO N/A
- EPS Growth
- ONB N/A
- HALO 63.33
- EPS
- ONB 1.68
- HALO 3.43
- Revenue
- ONB $1,761,532,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- ONB N/A
- HALO $23.48
- Revenue Next Year
- ONB $21.77
- HALO $18.16
- P/E Ratio
- ONB $13.96
- HALO $16.84
- Revenue Growth
- ONB N/A
- HALO 22.44
- 52 Week Low
- ONB $15.38
- HALO $37.73
- 52 Week High
- ONB $24.49
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- ONB 49.39
- HALO 62.93
- Support Level
- ONB $23.58
- HALO $56.07
- Resistance Level
- ONB $24.47
- HALO $60.67
- Average True Range (ATR)
- ONB 0.54
- HALO 1.43
- MACD
- ONB -0.10
- HALO -0.22
- Stochastic Oscillator
- ONB 28.97
- HALO 48.86
About ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.